New England Biolabs® Announces Agreement with AmpTec GmbH to supply key mRNA Synthesis Reagents
Ipswich, MA – New England Biolabs, Inc. (NEB®) has strengthened its position as a key supplier to the fast-growing RNA synthesis market by signing an agreement to supply critical reagents to AmpTec GmbH, a leading manufacturer of synthetic long RNAs and functional mRNAs for research, diagnostic and therapeutic applications. Under the terms of the agreement, NEB will manufacture and supply enzymes for in vitro transcription and capping of RNA.
Commenting on the relationship, AmpTec’s President and CEO, Guido Krupp stated, “NEB has a long track record as leading supplier of molecular biology enzymes and associated reagents for life science research. With this agreement, the strengths of NEB and AmpTec are combined to provide the market with the highest quality RNA for projects of all scales, from micrograms to grams.”
“We are pleased to formalize our relationship with AmpTec. By applying our technical and production expertise in enzyme chemistry, we can support AmpTec as a leading service provid

